Skip to main content
. 2013 Sep 5;35(4):221–227. doi: 10.1155/2013/276547

Table 2.

Seroprotection and seroconversion rates against pandemic H1N1 2009.

Immunogenicity Controller Noncontroller
Baseline proportion (%) After 1st dose proportion (%) After 2nd dose proportion (%) Baseline proportion (%) After 1st dose proportion (%) After 2nd dose proportion (%)
Seroprotection 14/29 (48.3) 19/29 (65.5) 21/29 (72.4) 5/16 (31.3) 7/16 (43.8) 8/16 (50.0)
Seroconversion N/A 13/29 (44.8) 16/29 (55.2) N/A 5/16 (31.3) 5/16 (31.3)

Note: N/A: non applicable.